A
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Amanda L. Dragan's research focuses on host-pathogen interactions, particularly concerning the bacterium *Coxiella burnetii*, the causative agent of Q fever. Her work investigates how this pathogen invades host cells and elicits inflammatory responses. Dr. Dragan has explored the potential of targeting neurotransmitter systems with drugs to inhibit *Coxiella burnetii* growth in human cells, as well as examining distinct inflammatory reactions produced by different strains of the bacterium in human macrophages. She has also contributed to studies utilizing primary human lung tissue models to understand pathogen invasion. Her research interests extend to the development of novel antibacterial agents, including work on the late-stage functionalization of rifamycin derivatives through click chemistry. Dr. Dragan has published six papers and has an h-index of 5 with 158 citations. She collaborates with researchers at the University of Arkansas for Medical Sciences, including Daniel E. Voth and Anette Dragan.
Metrics
- h-index: 5
- Publications: 10
- Citations: 160
Selected Publications
-
Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives (2026)
-
Coxiella burnetii Strains Elicit Distinct Inflammatory Responses in Human Macrophages (2025)
-
<i>Coxiella burnetii</i> strains elicit distinct inflammatory responses in human macrophages (2025)
-
Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells (2021)
-
Take my breath away: studying pathogen invasion of the human lung using primary tissue models (2021)
Collaboration Network
Top Collaborators
Daniel E. Voth
University of Arkansas for Medical Sciences
2 shared publications
In database
- Take my breath away: studying pathogen invasion of the human lung using primary tissue models
- Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells
Marissa S. Fullerton
University of Arkansas for Medical Sciences
2 shared publications
In database
- Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells
- Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives
Punsiri M. Colonne
University of Arkansas for Medical Sciences
1 shared publication
In database
- Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells
Katelynn R. Brann
University of Arkansas for Medical Sciences
1 shared publication
In database
- Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells
Richard C. Kurten
University of Arkansas for Medical Sciences
1 shared publication
In database
- Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells
Lola Beeser
Lyon College (US)
1 shared publication
- Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives
Daniel Armstrong
Lyon College (US)
1 shared publication
- Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives
Isabella Beasley
Lyon College (US)
1 shared publication
- Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives
Wyatt Treadway
Lyon College (US)
1 shared publication
- Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives
Clara Nikkel
Lyon College (US)
1 shared publication
- Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives
Mai Lan Ho
Lyon College (US)
1 shared publication
- Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives
Braden Glenn
Lyon College (US)
1 shared publication
- Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives
Catherine M. Mills
Lyon College (US)
1 shared publication
- Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives
Shailesh Budhathoki
Arkansas State University
1 shared publication
In database
- Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives
Jessie Parchman
Lyon College (US)
1 shared publication
- Late-Stage Functionalization of the Rifamycin Core via Click Chemistry Toward New Antibacterial Derivatives
Similar Researchers
Based on overlapping research topics
Madeleine G. Scott
University of Arkansas for Medical Sciences
Host-Pathogen Interactions
Microbial infections and disease research
Immune Response and Inflammation
Katelynn R. Brann
University of Arkansas for Medical Sciences
Host-Pathogen Interactions
Microbial infections and disease research
Immune Response and Inflammation
Marissa S. Fullerton
University of Arkansas for Medical Sciences
Host-Pathogen Interactions
Microbial infections and disease research
Immune Response and Inflammation
Shantanu Joshi
University of Arkansas at Fayetteville
Host-Pathogen Interactions
Microbial infections and disease research
Immune Response and Inflammation
Todd J. Spears
University of Arkansas for Medical Sciences
Host-Pathogen Interactions
Microbial infections and disease research
Immune Response and Inflammation
Punsiri M. Colonne
University of Arkansas for Medical Sciences
Host-Pathogen Interactions
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies